Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could spot cancer earlier in symptomatic patients

NCT ID NCT07046260

Diagnosis Sponsor: Harbinger Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing two new blood tests designed to help doctors detect cancer in people who have symptoms that might be cancer. The study will involve 1,650 adults aged 45 and older who are already undergoing medical tests for possible cancer. The goal is to see how well these blood tests can identify cancer, especially at early stages, which could lead to faster diagnosis and treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,650 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will enroll individuals 45 years of age or older who present with symptoms, signs, and/or have findings leading to a clinical suspicion or a diagnosis of one or more cancers originating from the following sites: * Biliary Tract * Colon * Esophagogastric Junction (EGJ) * Esophagus * Gallbladder * Head and Neck * Liver * Lung * Lymphatic System * Ovary * Pancreas * Rectum * Stomach

Ages

45 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subjects aged ≥45 years at the time of informed consent 2. Provided written or electronic informed consent, according to local guidelines, signed and dated by the Subject or by a legal guardian prior to the performance of any study- specific procedures, sampling, or analyses 3. Presentation with symptoms, signs, and/or findings that raise clinical suspicion of one or more of the protocol-specified sites AND 1. undergoing diagnostic work-up to determine if cancer is present, but do not yet have a confirmed cancer diagnosis. Subject must be willing to undergo a standard diagnostic work-up per local SoC to establish clinical truth regarding the presence or absence of cancer OR 2. have a confirmed diagnosis of cancer, determined within 90 days prior to signing the Informed Consent Form, based on standard diagnostic procedures (histopathology, imaging, etc.) following presentation with symptoms, signs, and/or findings that raised a clinical suspicion of one or more cancers originating from the protocol-specified sites. Must be treatment-naïve for the diagnosed cancer at the time of enrollment. Exclusion Criteria: 1. History of any prior invasive or hematological malignancy (Individuals with completely resected ductal carcinoma in-situ or completely resected non-melanoma skin cancer are permitted) 2. Subject is suffering from any febrile illness defined as a temperature \>101.5°F within 48 hours prior to blood draw 3. Subject is pregnant (Self-reported) 4. Subject is a recipient of an organ transplant, blood transfusion within 120 days, or prior non-autologous (allogeneic) bone marrow or stem cell transplant (Subject with a corneal transplant can be considered for study entry) 5. Inability or unwillingness to comply with study procedures or follow-up requirement 6. Previous or current participation in any study sponsored by, or employment with, Harbinger Health 7. Participation in a clinical research study sponsored by an external organization which may interfere with study procedures or outcomes 8. Subject has any condition that in the opinion of the Investigator should preclude participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer disease neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    35 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Activian Clinical Research

    RECRUITING

    Kingwood, Texas, 77339, United States

  • Activian Clinical Research (Scarsdale)

    RECRUITING

    Houston, Texas, 77089, United States

  • Associated Gastroenterologists of Central New York

    RECRUITING

    Fayetteville, New York, 13066, United States

  • Avita Clinical Research

    RECRUITING

    Tampa, Florida, 33613, United States

  • Azzi ENT and Facial Reconstructive Surgery

    RECRUITING

    Jupiter, Florida, 33477, United States

  • Cancer Care Associates of York

    RECRUITING

    York, Pennsylvania, 17403, United States

  • Cancer Center of Middle Georgia

    RECRUITING

    Dublin, Georgia, 31021, United States

    Contact Email: •••••@•••••

  • Capital Digestive Care

    WITHDRAWN

    Chevy Chase, Maryland, 20815, United States

  • Christie Clinic

    RECRUITING

    Champaign, Illinois, 61820, United States

  • GIA Clinical Trials, LLC

    RECRUITING

    Knoxville, Tennessee, 37909, United States

  • Gastroenterology of Greater Orlando

    RECRUITING

    Orange City, Florida, 32763, United States

  • Hightower Clinical

    RECRUITING

    Oklahoma City, Oklahoma, 73102, United States

  • Hope and Healing Cancer Services

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Huntsville Research Institute, LLC

    RECRUITING

    Huntsville, Texas, 77340, United States

  • Huron Gastroenterology

    WITHDRAWN

    Ypsilanti, Michigan, 48197, United States

  • Hutchinson Clinic

    RECRUITING

    Hutchinson, Kansas, 67502, United States

  • Iowa Clinic

    RECRUITING

    West Des Moines, Iowa, 50266, United States

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10021, United States

  • Millennium Medical Research

    RECRUITING

    Miami, Florida, 33126, United States

  • Millennium Physician Group

    WITHDRAWN

    Port Charlotte, Florida, 33952, United States

  • Northlake Gastroenterology Associates

    RECRUITING

    Hammond, Louisiana, 70403, United States

  • Oncology Hematology Specialists

    RECRUITING

    Mountain Lakes, New Jersey, 07046, United States

  • Palomar Health

    RECRUITING

    Poway, California, 92064, United States

  • Premier Family Physicians

    RECRUITING

    Austin, Texas, 78735, United States

  • Prophase, LLC

    RECRUITING

    Margate, Florida, 33063, United States

  • Pulmonary & Sleep Specialists of Northeast Georgia, P.C

    RECRUITING

    Winder, Georgia, 30680, United States

  • Regis Clinical Research

    RECRUITING

    Miami, Florida, 33126, United States

  • Respiratory Specialists

    RECRUITING

    Wyomissing, Pennsylvania, 19610, United States

  • Rocky Mountain Gastroenterology

    RECRUITING

    Centennial, Colorado, 80112, United States

  • South Coast Gynecologic Oncology

    RECRUITING

    San Diego, California, 92108, United States

  • Southern California Research Center

    RECRUITING

    Coronado, California, 92118, United States

  • Southwest Gastroenterology

    WITHDRAWN

    Albuquerque, New Mexico, 87109, United States

  • Stuart Oncology Associates

    RECRUITING

    Stuart, Florida, 34994, United States

  • Susquehanna Research Group

    RECRUITING

    Harrisburg, Pennsylvania, 17110, United States

  • Texas Digestive

    RECRUITING

    Harlingen, Texas, 78550, United States

  • Velocity Clinical Research

    RECRUITING

    Annapolis, Maryland, 21401, United States

  • Westchester Putnam Gastro

    RECRUITING

    Carmel, New York, 10512, United States

  • Wilmington Health, PLLC

    RECRUITING

    Wilmington, North Carolina, 28401, United States

  • Zoyla Almeida, MD PA

    RECRUITING

    Coconut Creek, Florida, 33073, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.